Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$660,885
+$184,445 QoQ
Shares Held
551
+6.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#3,509
of 4,605 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Weaver Consulting Group holds $4,407,808 across 7 Drug Manufacturers - General names. LLY ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,013 | $1,273,151 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,077 | $767,768 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
551 | $660,885 | |
| 4 | AMGN |
Amgen Inc
|
1,633 | $591,341 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,026 | $517,341 | |
| 6 | ABBV |
AbbVie Inc.
|
1,228 | $309,013 | |
| 7 | PFE |
Pfizer Inc
|
11,973 | $288,309 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $660,885 | 551 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $476,440 | 518 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $565,281 | 526 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $401,338 | 526 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $388,205 | 498 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $408,825 | 495 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $379,824 | 492 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $562,571 | 635 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $535,079 | 591 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $475,333 | 611 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $353,249 | 606 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $320,129 | 596 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $340,479 | 726 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $231,121 | 673 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $244,746 | 669 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $216,321 | 669 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $215,288 | 664 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $211,627 | 739 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $204,126 | 739 | Shares | Sole | 2022-02-01 | |
| 2020-09-30 | $94,732 | 640 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $105,075 | 640 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $87,532 | 631 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||